Filler for affinity chromatography
US-9162161-B2 · Oct 20, 2015 · US
US11667671B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11667671-B2 |
| Application number | US-202016911511-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 25, 2020 |
| Priority date | May 11, 2016 |
| Publication date | Jun 6, 2023 |
| Grant date | Jun 6, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a method of isolating an immunoglobulin, comprising the steps of:a) providing a separation matrix comprising at least 15 mg/ml multimers of immunoglobulin-binding alkali-stabilized Protein A domains covalently coupled to a porous support, wherein the porous support comprises cross-linked polymer particles having a volume-weighted median diameter (d50,v) of 56-70 micrometers and a dry solids weight of 55-80 mg/ml;b) contacting a liquid sample comprising an immunoglobulin with the separation matrix;c) washing the separation matrix with a washing liquid;d) eluting the immunoglobulin from the separation matrix with an elution liquid; ande) cleaning the separation matrix with a cleaning liquid comprising at least 0.5 M NaOH.
Opening claim text (preview).
What is claimed is: 1. A method of isolating an immunoglobulin, comprising the steps of: a) providing a separation matrix comprising at least 15 mg/ml multimers of immunoglobulin-binding alkali-stabilized Protein A domains covalently coupled to a porous support, wherein said porous support comprises cross-linked polymer particles having a pore size corresponding to an inverse gel filtration chromatography Kd value of 0.69-0.85 for dextran of Mw 110 kDa; b) contacting a liquid sample comprising an immunoglobulin with said separation matrix; c) washing said separation matrix with a washing liquid; d) eluting the immunoglobulin from the separation matrix with an elution liquid; and e) cleaning the separation matrix with a cleaning liquid comprising more than 2M NaOH, wherein in step e) the contact time between the separation matrix and the cleaning liquid is 3 minutes or less. 2. The method of claim 1 , wherein said separation matrix has a maximum pressure of at least 0.58 MPa when packed at 300+/−10 mm bed height in a chromatography column having a diameter of 35 mm. 3. The method of claim 1 , wherein said immunoglobulin comprises an Fc fusion protein. 4. The method of claim 1 , wherein said immunoglobulin has a hydrodynamic radius of at least 6.0 nm. 5. The method of claim 1 , wherein said immunoglobulin comprises a bispecific, trispecific or polyspecific antibody. 6. The method of claim 5 , wherein said method separates half antibodies or homodimeric antibodies from said bispecific, trispecific or polyspecific antibody. 7. The method of claim 1 , wherein said immunoglobulin comprises a conjugated antibody. 8. The method of claim 1 , wherein said immunoglobulin comprises an antibody fragment. 9. The method of claim 1 , wherein the separation matrix is a Protein A chromatography column. 10. The method of claim 1 , wherein steps b)-e) are repeated at least 10 times. 11. The method of claim 1 , wherein in step b) the pH is 6-8. 12. The method of claim 1 , wherein in step b) the residence time of said liquid sample on said separation matrix is 2-20 min. 13. The method of claim 1 , which is performed in a continuous or semicontinuous multicolumn chromatography process. 14. The method of claim 1 , which is performed in a periodic countercurrent chromatography (PCC) process. 15. The method of claim 1 , wherein the separation matrix is an antibody affinity chromatography cross-linked agarose matrix having alkaline-stabilized protein A-derived ligands.
Affinity chromatography or related techniques based upon selective absorption processes · CPC title
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title
using two or more columns · CPC title
Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation · CPC title
based on polymers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.